Premium
STUDIES ON THE EXPRESSION LEVELS OF STEROL‐METABOLIZING ENZYMES IN THE OBESE MODEL SHR/NDmcr‐ cp RATS
Author(s) -
Kudo Makiko,
Noshiro Mitsuhide,
Aoyama Yuri,
Yoshida Yuzo
Publication year - 2004
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.2004.04107.x
Subject(s) - cholesterol 7 alpha hydroxylase , cyp8b1 , sterol , enzyme , endocrinology , cholesterol , medicine , reductase , metabolism , chemistry , biology , biochemistry
SUMMARY 1. Expression levels of four key enzymes of cholesterol metabolism, namely 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG‐CoA) reductase, lanosterol 14‐demethylase (CYP51), cholesterol 7α‐hydroxylase (CYP7A1) and sterol 12α‐hydroxylase (CYP8B1), in metabolic syndrome model rats (SHR/NDmcr‐cp) were examined. 2. Decreased expression of CYP51, which may be linked to the development of obesity, was found in the rats. 3. Expression of CYP8B1 was significantly higher in young rats. 4. No substantial change was observed in the mRNA levels of the dominant rate‐limiting enzymes of sterol metabolism, namely HMG‐CoA reductase and CYP7A1, in the rats. 5. These findings suggest that the expression levels of two key enzymes managing the downstream parts of the cholesterol‐metabolizing pathways are altered in the rats, although little change was observed in the expression levels of the dominant rate‐limiting enzymes of cholesterol metabolism.